Table 3 Comparison of eGFR equations, the mean age of participants, number of female participants, and prevalence of risk factors and laboratory methods
Author | Region | Mean age of participants (Years) | Female Participants (Percentage) | Prevalence of Hypertension | Prevalence of Diabetes | Prevalence of HIV | KDIGO CKD criteria | Test for chronicity > 3 months | Serum creatinine measurement: enzyme or Jaffe | eGFR equations studied | Ethnicity co-efficient used |
|---|---|---|---|---|---|---|---|---|---|---|---|
Matsha et al. [19] | South Africa | 52.9 ± 14.8 | 75.3 | 33.0 | 26.0 | Not mentioned | No | No | Enzyme | CKD-EPI MDRD Cockcroft-Gault | Measured with and without ethnic co-efficient |
Adeniyi et al. [20] | South Africa | 46.3 ±8.5 | 70.3 | 55.2 | 20.7 | Not mentioned | No | No | Enzyme | CKD-EPI MDRD | No |
George et al. [8] | Sub-Saharan Africa | 49.9 ±5.8 | 49.2 | 32.6 | 5.6 | 15.9 | Yes | No | Enzyme | CKD-EPI MDRD | Measured with and without ethnic co-efficient |
Stanifer et al. [22] | Sub-Saharan Africa | 41.5 ± 4.1 | 57.5 | 16.8 | 17.1 | 11.9 | No | No | Not mentioned | MDRD Cockcroft-Gault | No |
Kaze et al. [12] | Africa | 43.0 ± 6.2 | Not mentioned | 35.6 | 13.3 | 17.9 | No | No | Not mentioned | CKD-EPI MDRD Cockcroft-Gault Cystatin C | No |
Abd ElHafeez et al. [11] | Africa | 52.8 ±11.7 | 64.3 | 34.4 | 24.7 | 5.6 | No | No | Enzyme and Jaffe | CKD-EPI MDRD Cockcroft-Gault | No |
Hill et al. [4] | Global | 49.0 ± 8.5 | 55.0 | 40.1 | 15.1 | Not mentioned | No | No | Enzyme and Jaffe | CKD-EPI MDRD | No |
Bikbov et al. [2] | Global | Not studied | Not mentioned | 43.2 | 57.6 | Not mentioned | Modelled | No | Not mentioned | CKD-EPI MDRD | No |